CoLucid Pharmaceuticals, Inc. 4
4 · CoLucid Pharmaceuticals, Inc. · Filed Aug 6, 2015
Insider Transaction Report
Form 4
Dallas Matthew D
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-08-04+30,000→ 30,000 totalExercise: $7.56Exp: 2025-08-04→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Options vest as to one-fourth of the shares on August 4, 2016 and as to the remaining shares in a series of 36 successive equal monthly installments upon completion of each additional month of service.